SAFE-BIOPHARMA® ASSOCIATION MERGES WITH NH-ISAC
ADDRESSING THE PROBLEM OF WEAK IDENTITY TRUST
The pharmaceutical industry developed the SAFE-BioPharma® digital signature and identity standards to address important challenges faced by healthcare companies every day: privacy, security, efficiency, and regulatory compliance. The merger between NH-ISAC and SAFE-BioPharma Association will help NH-ISAC members address important challenges around community-wide identity trust.
Continue with newsletter:CYBERFIT Newsletter 2018 Q1